Better understanding the neurobiology of primary lateral sclerosis

References

• Erb WH. Ueber einen wenig bekanten spinalen Symptomenkomplex. About a little-known spinal symptom complex. Berliner Klinische Wochenschrift 1875;26:357–9.
   Google Scholar
• Stark FM, Moersch FP. Primary lateral sclerosis. A distinct clinical entity. J Nerv Mental Dis. 1945;102:332–7.
   Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992;115: 495–520.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1:e3.
   PubMed Web of Science ®Google Scholar
• Gazulla J, Ferrer I, Izquierdo-Alvarez S, Alvarez S, Sanchez-Alcudia R, Bestue-Cardiel M, et al. Hereditary primary lateral sclerosis and progressive nonfluent aphasia. J Neurol. 2019;266:1079–90.
   PubMed Web of Science ®Google Scholar
• Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol Clin. 2015;33:749–60.
   PubMed Web of Science ®Google Scholar
• Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, et al. Primary lateral sclerosis and early upper motor neuron disease: characteristics of a cross-sectional population. J Clin Neuromuscul Dis. 2016;17:99–105.
   PubMedGoogle Scholar
• Charcot J-M, Joffroy A. Deux cas d’atrophie musculaire progressive avec lésion de la substance grise et des faisceaux de la moelle épinière. Arch Physiol 1869;2:354–67. 629–49; 744–60.
   Google Scholar
• Charcot JM. Sclérose des cordons latéraux. Gazette hébdomadaire 1865;7:109–110.
   Google Scholar
• Charcot JM. Leçons sur les Maladies du Système Nerveux faites à la Salpêtrière. Paris V: Aux Bureaux du Progrès Médical. Adrien Delahaye. Libraires-Editeurs 1877.
   Google Scholar
• Wais V, Rosenbohm A, Petri S, Kollewe K, Hermann A, Storch A, et al. The concept and diagnostic criteria of primary lateral sclerosis. Acta Neurol Scand. 2017;136:204–11.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. J Neurol. 2018;265:1819–28.
   PubMed Web of Science ®Google Scholar
• Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373–7.
   PubMed Web of Science ®Google Scholar
• Barohn RJ, Fink JK, Heiman-Patterson T, Huey ED, Murphy J, Statland JM, et al. The clinical spectrum of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.
   Google Scholar
• Gilmore M, Elman L, Babu S, Andres P, Floeter MK. Measuring PLS disease progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.
   PubMed Web of Science ®Google Scholar
• Silani V, Corcia P, Harms MB, Rouleau G, Siddique T, Ticozzi N. Genetics of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.
   Google Scholar
• Pioro E, Turner MR, Bede P. Neuroimaging in primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020 To appear.
   Web of Science ®Google Scholar
• de Carvalho M, Kiernan MC, Pullman SL, Rezania K, Simmons Z. Neurophysiological features of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. To appear.
   Google Scholar
• Mackenzie IRA, Briemberg H. TDP-43 pathology in primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020 Jul 11:1–7. DOI: 10.1080/21678421.2020.1790607
   Google Scholar
• Floeter MK, Warden D, Lange D, Wymer J, Paganoni S, Mitsumoto H. Clinical care and therapeutic trials in PLS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.
   Google Scholar
• Purves D. Neuroscience. 3d ed. Sunderland, MA: Sinauer Associates; 2007.
   Google Scholar
• The Thalamus and Cerebral Cortex (Integrative Systems) Part 1: What-when-how. In depth tutorials and information; Available at: http://what-when-how.com/neuroscience/the-thalamus-and-cerebral-cortex-integrative-systems-part-1/.
   Google Scholar
• Lemon RN. Descending pathways in motor control. Annu Rev Neurosci. 2008;31:195–218.
   PubMed Web of Science ®Google Scholar
• Lemon RN, Kirkwood PA, Maier MA, Nakajima K, Nathan P. Direct and indirect pathways for corticospinal control of upper limb motoneurons in the primate. Prog Brain Res. 2004;143:263–79.
   PubMed Web of Science ®Google Scholar
• Gautam M, Jara JH, Kocak N, Rylaarsdam LE, Kim KD, Bigio EH, et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47–69.
   PubMed Web of Science ®Google Scholar
• Genc B, Jara JH, Lagrimas AK, Pytel P, Roos RP, Mesulam MM, et al. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep. 2017;7:41765.
   PubMed Web of Science ®Google Scholar
• Shepherd GM. Diversity and complexity in the pyramidal tract projectome. Nat Rev Neurosci. 2014;15:63.
   PubMed Web of Science ®Google Scholar
• Harris KD, Shepherd GM. The neocortical circuit: themes and variations. Nat Neurosci. 2015;18:170–81.
   PubMed Web of Science ®Google Scholar
• Yamawaki N, Shepherd GM. Synaptic circuit organization of motor corticothalamic neurons. J Neurosci. 2015;35:2293–307.
   PubMed Web of Science ®Google Scholar
• Hooks BM, Mao T, Gutnisky DA, Yamawaki N, Svoboda K, Shepherd GM. Organization of cortical and thalamic input to pyramidal neurons in mouse motor cortex. J Neurosci. 2013;33:748–60.
   PubMed Web of Science ®Google Scholar
• Suter BA, Yamawaki N, Borges K, Li X, Kiritani T, Hooks BM, et al. Neurophotonics applications to motor cortex research. Neurophoton. 2014;1:011008.
   PubMed Web of Science ®Google Scholar
• Turner M, Cosgrove J, Jamieson S, Chowdhury FU. Teaching neuroimages: hypometabolism of the primary motor cortex in primary lateral sclerosis: the stripe sign. Neurology 2016;86:1464.
   PubMed Web of Science ®Google Scholar
• Suter BA, Migliore M, Shepherd GM. Intrinsic electrophysiology of mouse corticospinal neurons: a class-specific triad of spike-related properties. Cereb Cortex. 2013;23:1965–77.
   PubMed Web of Science ®Google Scholar
• Jara JH, Sheets PL, Nigro MJ, Peric M, Brooks C, Heller DB, et al. The electrophysiological determinants of corticospinal motor neuron vulnerability in ALS. Front Mol Neurosci 2020;13:e00073.
   PubMed Web of Science ®Google Scholar
• Vucic S, Kiernan MC. Transcranial magnetic stimulation for the assessment of neurodegenerative disease. Neurotherapeutics. 2017;14:91–106.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Koch G, Hillis AE, Huynh W, Ward NS, Vucic S, et al. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke. J Neurol Neurosurg Psychiatry. 2019;90:47–57.
   PubMed Web of Science ®Google Scholar
• Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann NY Acad Sci. 2005;1064:61–77.
   PubMed Web of Science ®Google Scholar
• Fogarty MJ, Klenowski PM, Lee JD, Drieberg-Thompson JR, Bartlett SE, Ngo ST, et al. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep. 2016;6:37968.
   PubMed Web of Science ®Google Scholar
• Jara JH, Villa SR, Khan NA, Bohn MC, Ozdinler PH. AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS. Neurobiol Dis. 2012;47:174–83.
   PubMed Web of Science ®Google Scholar
• Jara JH, Genc B, Cox GA, Bohn MC, Roos RP, Macklis JD, et al. Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function. Cereb Cortex. 2015;25:4259–72.
   PubMed Web of Science ®Google Scholar
• Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Ozdinler PH. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum Mol Genet. 2016;25:1074–87.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Alshikho MJ, Zurcher NR, Cernasov P, Babu S, Loggia ML, et al. Imaging of glia activation in people with primary lateral sclerosis. Neuroimage Clin. 2018;17:347–53.
   PubMed Web of Science ®Google Scholar
• Lemon R. Recent advances in our understanding of the primate corticospinal system. F1000Res. 2019;8:274.
   Google Scholar
• Genc B, Ozdinler PH. Moving forward in clinical trials for ALS: motor neurons lead the way please. Drug Discovery Today. 2014;19:441.
   PubMed Web of Science ®Google Scholar
• Genc B, Gozutok O, Ozdinler PH. Complexity of generating mouse models to study the upper motor neurons: let us shift focus from mice to neurons. Int J Mol Sci. 2019;20:3848.
   Web of Science ®Google Scholar
• Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet. 2003;12:1671–87.
   PubMed Web of Science ®Google Scholar
• Topp JD, Carney DS, Horazdovsky BF. Biochemical characterization of Alsin, a Rab5 and Rac1 guanine nucleotide exchange factor. Methods Enzymol. 2005;403:261–76.
   PubMed Web of Science ®Google Scholar
• Hadano S, Benn SC, Kakuta S, Otomo A, Sudo K, Kunita R, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet. 2006;15:233–50.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160–5.
   PubMed Web of Science ®Google Scholar
• Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002;71:518–27.
   PubMed Web of Science ®Google Scholar
• Simone M, Trabacca A, Panzeri E, Losito L, Citterio A, Bassi MT. KIF5A and ALS2 variants in a family with hereditary spastic paraplegia and amyotrophic lateral sclerosis. Front Neurol 2018;9:1078.
   PubMed Web of Science ®Google Scholar
• Cai H, Lin X, Xie C, Laird FM, Lai C, Wen H, et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci. 2005;25:7567–74.
   PubMed Web of Science ®Google Scholar
• Deng HX, Zhai H, Fu R, Shi Y, Gorrie GH, Yang Y, et al. Distal axonopathy in an alsin-deficient mouse model. Hum Mol Genet. 2007;16:2911–20.
   PubMed Web of Science ®Google Scholar
• Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, Cao LP, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci USA. 2006;103:9595–600.
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann Neurol. 2006;60:95–104.
   PubMed Web of Science ®Google Scholar
• Yasvoina MV, Genc B, Jara JH, Sheets PL, Quinlan KA, Milosevic A, et al. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model. J Neurosci. 2013;33:7890–904.
   PubMed Web of Science ®Google Scholar
• Haase G, Rabouille C. Golgi fragmentation in ALS motor neurons. New mechanisms targeting microtubules, tethers, and transport vesicles. Front Neurosci. 2015;9:448.
   PubMed Web of Science ®Google Scholar
• Rabouille C, Haase G. Editorial: golgi pathology in neurodegenerative diseases. Front Neurosci. 2015;9:489.
   PubMed Web of Science ®Google Scholar
• Jacquier A, Buhler E, Schäfer MK, Bohl D, Blanchard S, Beclin C, et al. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann Neurol. 2006;60:105–17.
   PubMed Web of Science ®Google Scholar
• Lai C, Xie C, Shim H, Chandran J, Howell BW, Cai H. Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin. Mol Brain. 2009;2:23.
   PubMed Web of Science ®Google Scholar
• Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem. 2004;279:24612–23.
   PubMed Web of Science ®Google Scholar
• Otomo A, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Onoe K, Osuga H, et al. ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth. Biochem Biophys Res Commun. 2008;370:87–92.
   PubMed Web of Science ®Google Scholar
• Hadano S, Otomo A, Kunita R, Suzuki-Utsunomiya K, Akatsuka A, Koike M, et al. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS One. 2010;5:e9805
   PubMed Web of Science ®Google Scholar
• Hsu F, Spannl S, Ferguson C, Hyman AA, Parton RG, Zerial M. Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria. Elife. 2018;7:e32282.
   PubMed Web of Science ®Google Scholar
• Jacquier A, Bellouze S, Blanchard S, Bohl D, Haase G. Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function. Hum Mol Genet. 2009;18:2127–39.
   PubMed Web of Science ®Google Scholar
• Magrane J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413–24.
   PubMed Web of Science ®Google Scholar
• Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci USA. 2010;107:21146–51.
   PubMed Web of Science ®Google Scholar
• Millecamps S, Gentil BJ, Gros-Louis F, Rouleau G, Julien JP. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta. 2005;1745:84–100.
   PubMed Web of Science ®Google Scholar
• Scialo C, Morbelli S, Girtler N, Mandich P, Mancardi GL, Caponnetto C, et al. Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:414–7.
   PubMed Web of Science ®Google Scholar
• Mills CK. A case of unilateral progressive ascending paralysis, probably representing a new form of degenerative disease. J Nerv Ment Dis 1900;27:195–200.
   Google Scholar
• Gastaut JL, Bartolomei F. Mills’ syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis? J Neurol Neurosurg Psychiatry. 1994;57:1280–1.
   PubMed Web of Science ®Google Scholar
• Beach RL, Rao JS, Festoff BW, Reyes ET, Yanagihara R, Gajdusek DC. Collagenase activity in skin fibroblasts of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1986;72:49–60.
   PubMed Web of Science ®Google Scholar
• Ono S, Imai T, Tsumura M, Takahashi K, Jinnai K, Suzuki M, et al. Increased serum hyaluronic acid in amyotrophic lateral sclerosis: relation to its skin content. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:213–8.
   PubMed Web of Science ®Google Scholar
• Tsukie T, Masaki H, Yoshida S, Fujikura M, Ono S. Decreased Amount of Collagen in The Skin of Amyotrophic Lateral Sclerosis in The Kii Peninsula of Japan. Acta Neurol Taiwan 2014;23:82–9.
   PubMedGoogle Scholar
• Yang S, Zhang KY, Kariawasam R, Bax M, Fifita JA, Ooi L, et al. Evaluation of skin fibroblasts from amyotrophic lateral sclerosis patients for the rapid study of pathological features. Neurotox Res. 2015;28:138–46.
   PubMed Web of Science ®Google Scholar
• Oketa Y, Higashida K, Fukasawa H, Tsukie T, Ono S. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis. Acta Neurol Scand. 2013;128:257–64.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Okeda Y, Yamano T, Ono S. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2010;298:52–6.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mikami H, Watanabe T, Yamano T, Yamazaki T, Nomura M, et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:367–72.
   PubMed Web of Science ®Google Scholar
• Kirk K, Gennings C, Hupf JC, Tadesse S, D’Aurelio M, Kawamata H, et al. Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol. 2014;76:620–4.
   PubMed Web of Science ®Google Scholar
• Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci 2014;8:131.
   PubMed Web of Science ®Google Scholar
• Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener. 2017;12:76.
   PubMed Web of Science ®Google Scholar
• Borroni MV, Valles AS, Barrantes FJ. The lipid habitats of neurotransmitter receptors in brain. Biochim Biophys Acta. 2016;1858:2662–70.
   PubMed Web of Science ®Google Scholar
• Ingolfsson HI, Melo MN, van Eerden FJ, Arnarez C, Lopez CA, Wassenaar TA, et al. Lipid organization of the plasma membrane. J Am Chem Soc. 2014;136:14554–9.
   PubMed Web of Science ®Google Scholar
• Arima H, Omura T, Hayasaka T, Masaki N, Hanada M, Xu D, et al. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Neuroscience 2015;297:127–36.
   PubMed Web of Science ®Google Scholar
• Henriques A, Croixmarie V, Priestman DA, Rosenbohm A, Dirrig-Grosch S, D’Ambra E, et al. Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum Mol Genet. 2015;24:7390–405.
   PubMed Web of Science ®Google Scholar
• Henriques A, Huebecker M, Blasco H, Keime C, Andres CR, Corcia P, et al. Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis . Sci Rep. 2017;7:5235.
   PubMed Web of Science ®Google Scholar
• Okumiya K, Sakamoto R, Ishimoto Y, Kimura Y, Fukutomi E, Ishikawa M, et al. Glucose intolerance associated with hypoxia in people living at high altitudes in the Tibetan highland. BMJ Open. 2016;6:e009728.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:133–145.
   PubMed Web of Science ®Google Scholar
• Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther. 2012;23:382–9.
   PubMed Web of Science ®Google Scholar
• Bravo-Hernandez M, Tadokoro T, Navarro MR, Platoshyn O, Kobayashi Y, Marsala S, et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat Med. 2020;26:118–30.
   PubMed Web of Science ®Google Scholar
• Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, et al. Towards a transgenic model of Huntington’s disease in a non-human primate. Nature 2008;453:921–4.
   PubMed Web of Science ®Google Scholar
• Cathomen T, Ehl S. Translating the genomic revolution – targeted genome editing in primates. N Engl J Med. 2014;370:2342–5.
   PubMed Web of Science ®Google Scholar
• Ozdinler PH, Silverman RB. Treatment of amyotrophic lateral sclerosis: lessons learned from many failures. ACS Med Chem Lett. 2014;5:1179–81.
   PubMed Web of Science ®Google Scholar
• Guo W, Fumagalli L, Prior R, Van Den Bosch L. Current advances and limitations in modeling ALS/FTD in a dish using induced pluripotent stem cells. Front Neurosci. 2017;11:671.
   PubMed Web of Science ®Google Scholar
• Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci. 2012;15:477–86, S1.
   PubMed Web of Science ®Google Scholar
• Motono M, Ioroi Y, Ogura T, Takahashi J. WNT-C59, a small-molecule WNT inhibitor, efficiently induces anterior cortex that includes cortical motor neurons from human pluripotent stem cells. Stem Cells Transl Med. 2016;5:552–60.
   PubMed Web of Science ®Google Scholar
• Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature 2013;501:373–9.
   PubMed Web of Science ®Google Scholar
• Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Brauninger M, et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci USA. 2015;112:15672–7.
   PubMed Web of Science ®Google Scholar
• Ormel PR, Vieira de Sa R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, et al. Microglia innately develop within cerebral organoids. Nat Commun. 2018;9:4167.
   PubMed Web of Science ®Google Scholar
• Quadrato G, Nguyen T, Macosko EZ, Sherwood JL, Min Yang S, Berger DR, et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 2017;545:48–53.
   PubMed Web of Science ®Google Scholar